How Do You Spell MYELOMATOSIS?

1. Myelomatosis is a medical term that refers to a serious and malignant disorder characterized by the abnormal growth and multiplication of plasma cells in the bone marrow. Specifically, it is an aggressive form of multiple myeloma, a type of cancer that primarily affects the bone marrow and compromises its normal functions.

   In individuals with myelomatosis, there is an excessive production of abnormal plasma cells, which are a type of white blood cells responsible for producing antibodies. These abnormal plasma cells accumulate in the bone marrow, crowding out and inhibiting the normal production of healthy blood cells, such as red blood cells, white blood cells, and platelets. As a result, the affected individual may experience various symptoms, including bone pain, anemia, increased susceptibility to infections, fatigue, and kidney dysfunction.

   The causes of myelomatosis are still not completely understood, although certain risk factors have been identified, such as genetic predisposition, exposure to radiation or certain chemicals, and old age. The diagnosis of myelomatosis typically involves a combination of medical history evaluation, physical examination, blood tests, bone marrow biopsy, and imaging studies.

   Treatment options for myelomatosis may include chemotherapy, radiation therapy, targeted drug therapies, immunotherapy, and stem cell transplantation, depending on the stage and severity of the disease. Although myelomatosis is generally considered incurable, advancements in medical treatments have significantly improved the prognosis and overall survival rates for affected individuals in recent years. Regular monitoring and follow-up care are essential for managing the condition and minimizing complications.

2. Myeloma multiplex, Kahler's disease; a disease characterized by pernicious anemia, albumosuria, fever of an intermittent type, pains in the bones and joints, and the occurrence of multiple tumors of the red marrow leading to absorption of the bone and consequent fractures. The lymph nodes and spleen are not affected and metastases do not occur. Called also lymphadenia ossium, myelogenous pseudoleucemia, malignant osteomyelitis, and sarcomatous osteitis.

   A practical medical dictionary. By Stedman, Thomas Lathrop. Published 1920.

Common Misspellings for MYELOMATOSIS

The word "myelomatosis" is derived from two main components, "myelo" and "matosis".

1. "Myelo" - This prefix is derived from the Greek word "muelos" which means "marrow". It often refers to bone marrow in medical terminology.

2. "Matosis" - This suffix is derived from the Greek word "matos", which means "tumor" or "swelling". It is often used in medical terminology to indicate a pathological condition characterized by the abnormal growth or proliferation of cells.

Therefore, the word "myelomatosis" combines these two components to describe a pathological condition characterized by the abnormal growth or proliferation of cells in the bone marrow. Specifically, it is commonly used to refer to multiple myeloma, a type of cancer that affects plasma cells in the bone marrow.